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Allergic Reactions to Foods in Preschool-Aged
Children in a Prospective Observational Food Allergy
Study
WHAT’S KNOWN ON THIS SUBJECT: Infants and children with
diagnosed food allergy are at risk for acute, potentially life-threatening
symptoms. Limited data are available on the frequency, severity, and
circumstances of reactions and caretaker medical response.
WHAT THIS STUDY ADDS: This study describes food allergy
reaction frequency, circumstances, and response. Pitfalls that
may inform improved anticipatory guidance included lack of
vigilance, misreading ingredient labels, allergen cross-contact,
nonaccidental allergen feeding, and underutilization of
epinephrine for severe reactions.
abstract
OBJECTIVE: To examine circumstances of allergic reactions to foods in
a cohort of preschool-aged children.
METHODS: We conducted a prospective, 5-site observational study of
512 infants aged 3 to 15 months with documented or likely allergy
to milk or egg, and collected data prospectively examining allergic
reactions.
RESULTS: Over a median follow-up of 36 months (range: 0–48.4), the
annualized reaction rate was 0.81 per year (367/512 subjects reporting
1171 reactions [95% confidence interval: 0.76–0.85]). Overall, 269/512
(52.5%) reported .1 reaction. The majority of reactions (71.2%) were
triggered by milk (495 [42.3%]), egg (246 [21.0%]), and peanut (93
[7.9%]), with accidental exposures attributed to unintentional ingestion,
label-reading errors, and cross-contact. Foods were provided by persons
other than parents in 50.6% of reactions. Of 834 reactions to milk, egg, or
peanut, 93 (11.2%) were attributed to purposeful exposures to these avoided
foods. A higher number of food allergies (P , .0001) and higher food-
specific immunoglobulin E (P , .0001) were associated with reactions. Of
the 11.4% of reactions (n = 134) that were severe, 29.9% were treated with
epinephrine. Factors resulting in undertreatment included lack of
recognition of severity, epinephrine being unavailable, and fears about
epinephrine administration.
CONCLUSIONS: There was a high frequency of reactions caused by acci-
dental and nonaccidental exposures. Undertreatment of severe reactions
with epinephrine was a substantial problem. Areas for improved educa-
tion include the need for constant vigilance, accurate label reading,
avoidance of nonaccidental exposure, prevention of cross-contamination,
appropriate epinephrine administration, and education of all caretakers.
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Allergic reactions to foods affect up to
8%of children.1 Food allergy appears to
be increasing in prevalence,2 can be
severe,1 and potentially fatal.3 Manage-
ment requires avoidance of the trigger
foods and treatment of anaphylaxis
promptly with epinephrine.4 Errors in
daily management can result in allergic
reactions and undertreatment of severe
reactions.5–16
The primary aim of this study was to
determine the frequency and circum-
stances of allergic reactions to foods,
and treatment responses, in a pro-
spective study of infants and preschool-
aged children with likely egg or milk
allergies. The cohort we examined is
participating in an observational study
on the natural course of milk/egg al-
lergy and is being observed for the
development of peanut allergy.17,18 Egg,
milk, and peanut allergies are a focus
of this study because they represent
the most common food allergies in this
age group,1 and participants were in-
structed to avoid these foods if toler-
ance was not documented. However, we
include data on allergic reactions to any
foods to examine the full scope of the
problem. Understanding the circumstan-
ces of allergic reactions can potentially
inform educational and treatment strat-




Characteristics of the participants have
been reported.17,18 Briefly, 512 infants,
ages 3 to 15 months, were enrolled at 5
US sites (New York, NY; Baltimore, MD;
Little Rock, AR; Denver, CO; and Durham,
NC) by advertisement through pediat-
ric and allergy practices. Infants ful-
filled at least 1 of 2 enrollment criteria:
(1) convincing allergic reaction to milk
and/or egg with a positive prick skin
test to the trigger food(s) (n = 308)
and/or (2) moderate to severe atopic
dermatitis and a positive prick skin
test to milk and/or egg (n = 204).17,19 Of
616 children originally presenting for
screening in the study, 104 were not
enrolled at screening for previously
documented peanut allergy because
the aim of the cohort was to follow chil-
dren for development of this allergy.17,18
Nonetheless, 68.8% of the cohort were
already sensitized to peanut, with 26.6%
fulfilling a serologic diagnosis.20 Subjects
were classified as allergic according to
the clinical history and food-specific im-
munoglobulin E (IgE) levels.17
Study procedures were approved by a
data safety monitoring board and local
institutional reviewboards, andwritten
consents were obtained. Participants
werescheduled foraclinicalevaluationat
6-month intervals for 2 visits, and then
yearly, with telephone contacts between
each visit. Participants received written
andverbal foodallergenavoidanceadvice
for the specific foods to which they were
allergic and written emergency plans
with prescriptions for self-injectable epi-
nephrine.Advice regarding introduction
of foods followed 2000 American Acad-
emyof Pediatricsguidelinesactive at the
time of enrollment.21
Documentation of Acute Allergic
Reactions and Severity Grading
A structured 36-item questionnaire,
modified from ones used previously,5,6,14
was used to obtain details about the
reaction including the symptoms and
their timing, the trigger, route of expo-
sure, person providing the food, circum-
stances of exposure (accidental, nature
of accident or error, purposefulness,
etc), and detailed response to the re-
action symptoms. A reaction was in-
cluded in the study if IgE-mediated
symptoms (eg, urticaria, angioedema,
wheezing, etc) developed within 2 hours
of ingestion. Participants were instruc-
ted to contact the study site at the time
of reactions. Additionally, participants
were queried at every clinical visit and
telephone follow-up, as described above.
Nonaccidental (purposeful) exposures
were those where the food was know-
ingly given. Due to the subjects’ ages,
reactions resulting from children self-
feeding the culprit food were considered
accidental. Reactions during medically
supervised feedings were excluded.
Reaction severity was graded based
upon Perry et al16 as mild (skin and/or
oral symptoms and/or upper respira-
tory symptoms but not all 3 organ
systems); moderate (skin, oral, and up-
per respiratory symptoms, or gastroin-
testinal symptoms); and severe (lower
respiratory symptoms, cardiovascular
symptoms or a combination of skin, oral,
upper respiratory and gastrointestinal
symptoms).
Statistical Methods
The annualized rate of reactions was
calculated by summing the number of
reactions across subjects and dividing
by the number of follow-up years. To
identify associations, univariate Pois-
son regressionanalysiswasperformed
to examine demographic/laboratory fac-
torswhere the numberof reactionswas
the outcome variable; each factor was
tested as a predictor, with the number
of follow-up years as the offset.
Pairwise comparisons were made to
evaluate whether purposeful exposure
was similarly common for milk (or egg)
versus peanut. Information from cases
where reactions to both foods were ob-
served (McNemar’s test) was combined
with information from isolated food
reactions (Fisher’s exact test) by using
Fisher’s method for combining P values.
To evaluate potential escalation of se-
verity with repeated exposures to milk,
egg, or peanut, severity from the first
reaction was subtracted from the se-
verityofthesecond(mild=1,moderate=
2, severe = 3), and the difference was
analyzed by using the signed rank test.
Repeated measures analyses, which
took into account multiple reactions
from the samesubject,wereperformed
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to compare outcomes for milk or egg
compared with peanut by using a gen-
eralized linear model with a multino-
mial distribution (3 severity grades, by
using PROC GENMOD SAS 9.2; SAS In-
stitute, Inc, Cary, NC).
RESULTS
Subject Characteristics
A total of 512 children with a median of
35.5 months (range: 0–48.4) follow-up
were included (1 infant died and 1 dis-
continued participation in the month
after enrollment). Demographic char-
acteristics of the participants have been
previously reported.17,18 Based on pre-
viously defined criteria from baseline
data and food-specific IgE,17 173 sub-
jects had no confirmed baseline food
allergy, 278 had 1 (milk or egg), and 53
had both. Where allergy diagnosis was
uncertain, families were instructed to
avoid egg, milk, or peanut pending me-
dically supervised oral food challenges,
or per advice regarding introduction of
foods following the 2000 American
Academy of Pediatrics guidelines active
at the time of enrollment (eg, peanut to
be introduced after age 3 years).21 Over
the period of observation, 97.9% of
participants were retained.
Allergic Reactions for All Foods
A total of 1171 reactions were reported
by 367 (71.7%) subjects. More than 1
reaction was reported by 269 partic-
ipants (52.5%). Table 1 shows the per-
cent of subjects experiencing reactions,
and Fig 1 shows the percent of allergic
reactions to each food. The annualized
rates of reactions were 0.81 per year
overall (95% confidence interval [CI]:
0.76–0.85), with milk 0.34 per year (95%
CI: 0.31–0.37), egg 0.17 per year (95% CI:
0.15–0.19), and peanut 0.06 per year
(95% CI: 0.05–0.08), as shown in Table 2.
The median time between a reaction
and the time it was reported was 26
days (range, 0–382; 95% CI: 23–29).
TABLE 1 Percent of Subjects With Acute Allergic Reactions According to Baseline Features
N % of Subjects With Reactions
All Milk Egg Peanut Other
Overall
All subjects 512 71.7 42.4 30.3 13.5 35.2
Age, mo
3–5 65 61.5 38.5 21.5 13.8 32.3
6–8 128 69.5 37.5 24.2 10.9 38.3
9–12 182 76.9 50.0 34.1 11.5 37.9
13–15 137 71.5 38.7 35.0 18.2 29.9
Gender
Boy 345 74.2 45.8 29.9 13.6 33.0
Girl 167 66.5 35.3 31.1 13.2 39.5
Race
White 380 72.4 43.9 32.1 12.1 33.7
African American 78 67.9 35.9 30.8 17.9 38.5
Asian 44 65.9 40.9 15.9 15.9 31.8
Other 10 100 40.0 20.0 20.0 80.0
Sitea
National Jewish Health 99 77.8 40.4 34.3 18.2 34.3
Duke University 103 47.6 33.0 11.7 5.8 6.8
Johns Hopkins University 109 70.6 45.9 24.8 9.2 38.5
Mount Sinai Medical Center 107 80.4 43.9 31.8 11.2 58.9
University of Arkansas 94 83.0 48.9 51.1 24.5 36.2
Baseline no. of food allergiesa
None (no milk, no egg) 173 66.5 28.3 26.0 13.3 37.6
1 (either milk or egg) 278 72.3 45.0 29.5 13.7 33.1
2 (both milk and egg) 53 83.0 71.7 45.3 11.3 35.8
Household incomea
,$50 000 86 74.4 39.5 43.0 19.8 33.7
$50 000–$99 000 135 66.7 40.0 25.2 13.3 30.4
$$100 000 215 75.3 48.4 27.0 10.7 39.1
Maternal education
High school or less 56 69.6 30.4 41.1 21.4 30.4
Some college/college degree 245 74.3 44.5 27.8 13.1 35.9
Graduate degree 208 69.2 42.8 30.3 11.5 35.6
Paternal educationa
High school or less 90 74.4 37.8 44.4 22.2 33.3
Some college/college degree 209 75.1 45.5 28.7 13.4 36.8
Graduate degree 206 68.9 42.2 26.2 9.7 35.0
Baseline milk IgE, kUA/Lb
,0.35 194 52.1 13.4 25.8 14.4 25.8
$0.35–2 111 73.9 39.6 34.2 10.8 32.4
$2–5 64 79.7 51.6 37.5 15.6 40.6
$5 134 93.3 81.3 28.4 12.7 47.0
Baseline egg IgE, kUA/Lb
,0.35 129 53.5 32.6 13.2 4.7 22.5
$0.35–2 119 62.2 30.3 23.5 9.2 30.3
$2–5 81 82.7 48.1 43.2 18.5 30.9
$5 174 85.6 54.6 40.2 20.1 48.9
Baseline peanut IgE, kUA/Lb
,0.35 198 57.6 32.3 23.2 4.5 23.2
$0.35–2 105 71.4 41.0 30.5 11.4 37.1
$2–5 60 78.3 41.7 41.7 16.7 36.7
$5 140 87.9 57.1 33.6 25.7 48.6
Baseline atopic dermatitis
None 41 61.0 43.9 17.1 4.9 24.4
Mild 50 72.0 46.0 36.0 6.0 26.0
Moderate 258 70.9 44.6 31.4 14.7 34.1
Severe 163 75.5 37.4 30.1 16.0 42.3
Have siblings
No 223 75.3 44.8 35.0 14.3 33.2
Yes 289 68.9 40.5 26.6 12.8 36.7
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We evaluated baseline demographic
and laboratory data (Table 1) to de-
termine characteristics that may be
associated with reactions. Significant
associations as shown in Table 1 in-
cluded clinical site, higher number of
baseline food allergies, paternal edu-
cation of high school or less, being in
lower or higher than median income
brackets, and higher baseline allergen-
specific IgE. Other baseline character-
istics that were not associated include
age, atopic dermatitis, breastfeeding
history, parental atopy, and having
siblings.
Circumstances of Reactions to
Milk, Egg, and Peanut
Of the 834 reactions to milk, egg, or
peanut, 729 (87.4%) were due to acci-
dental exposures. Causes of accidental
reactions included the following: un-
intentional ingestions (eg, purely acci-
dental such as forgetfulness, reduced
supervision, not checking a product,
etc), 473 (64.9%); label reading error,
115 (15.8%); cross-contamination, 110
(15.1%); error in preparation, 30 (4.1%);
and manufacturer labeling error, 1
(0.1%). Of 729 accidental exposures,
parents were most often providers of
the food (36.2%), followed by the pa-
tients (26.5%), and then various rela-
tives and caregivers (Fig 2). Regarding
reactions categorized as being due to
nonaccidental ingestion of avoided foods
(n = 93), parents were the most com-
mon providers (87.1%), followed by
grandparents (9.7%), and others (3.2%).
There were 12 reactions (1.4%) catego-
rized as purposeful but not occurring
during avoidance of milk, egg, or pea-
nut; examples included new onset re-
actions or reactions to foods containing
larger allergen amounts than previously
tolerated. Nonaccidental exposure, com-
pared with accidental, wasmore likely to
occur for milk (P = .03) or egg (P = .01)
compared with peanut.
Routes of exposure were characterized
as ingestion alone (80.7%), skin alone
(12.9%), ingestion plus skin (4.5%), in-
halationalone (1.2%), orother (0.7%). The
severity of reactions from all foods with
respect to route of exposure is shown in
Fig 3, indicating that ingestion was the
primary route causing severe reactions.
Severity and Treatment of Milk,
Egg, and Peanut Reactions
Reaction severity for milk, egg, and
peanut is shown in Table 3. The severity
of reactions ranked from highest to
lowestwas peanut.milk. egg, where
the difference between peanut and
egg was statistically significant (P =
.005), but the difference between pea-
nut and milk was not (P = .06). Table 3
also summarizes the medications used
to treat reactions. Parents treated 58.9%
of milk, egg, or peanut reactions,
other persons 4.9%, teachers 3.4%,
and school nurses 0.2%. Overall, there
TABLE 1 Continued
N % of Subjects With Reactions
All Milk Egg Peanut Other
Breastfeeding history
Never 73 75.3 41.1 43.8 20.5 31.5
Yes, currently 177 70.1 49.2 24.3 8.5 38.4
Yes, but no longer breastfeeding 262 71.8 38.2 30.5 14.9 34.0
Parental history of atopy
Neither parent 75 66.7 46.7 29.3 12.0 28.0
1 parent 205 68.8 38.0 30.2 12.7 35.1
Both parents 223 75.8 44.4 29.6 14.3 38.1
kUA/L, kilounits of antibody per liter.
a P value from Poisson regression for all reactions was ,.0005.
b P value from Poisson regression was ,.0001 for the following risk factor analyses: baseline milk IgE for milk reactions,
baseline egg IgE for egg reactions, and baseline peanut IgE for peanut reactions.
FIGURE 1
Allergic reactions per food allergen.
TABLE 2 Annualized Rates of Allergic
Reactions
Food Annualized Rate of Reactions 95% CI
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was no treatment provided in 21.3% of
reactions.
When comparing first and second
same-food reactions (milk: 123; egg: 58;
peanut: 19), no differences were detec-
ted for milk, P = .20, egg, P = .63, or
peanut, P = .13, indicating no escalation
of severity. However, when the first re-
action to milk was compared with the
fourth from the same subject (n = 48),
an increase in severity was found (P =
.002); this increase was not seen for any
other comparisons (first to third, P =
.09; second to third, P = .23; third to
fourth, P = .56). Too few subjects had 3




Of 52 reactions treated with epineph-
rine (Table 3), triggers were milk (15),
peanut (7), egg (6), wheat (4), fish (3),
shrimp (1), walnut (1), others (4), and
uncertain food (11). Severity grading of
52 reactions treated with epinephrine
were severe (40), moderate (4), and
mild (8). Data were analyzed to assess
epinephrine use according to reaction
severity, with all severe reactions war-
ranting epinephrine administration based
on current guidelines.4 Of the 1171 re-
actions, 134 (11.4%) were severe, and
theminority (40/134 [29.9%])were treated
with epinephrine.
There were 65 reactions in which epi-
nephrine was not given during a re-
action, even thoughcaretakersadmitted
in retrospect that epinephrine was
warranted. The reasons for not injecting
epinephrine included the following: re-
action not recognized (47.7%), epine-
phrine unavailable (23.1%), too afraid
(12.3%), waiting for more symptoms
(6.2%), and unsure if needed (3.1%).
DISCUSSION
This is the first large-scale, multicenter,
prospective study evaluating the fre-
quency and circumstances of reactions
due to multiple foods in children with
a certain or likely diagnosis, having re-
ceived avoidance advice. Our cohort
comprised infants and preschool-aged
children enrolled with likely milk or
egg allergy, at risk for peanut allergy,
a common clinical presentation of food
allergy for this age group.17,18 We de-
scribe a large number of reactions
(1171), their circumstances, and treat-
ment response. Key findings and their
implications are highlighted in Table 4.
The few previous studies about rates
of reactions typically focus on older
FIGURE 2
Allergic reactions per individual who provided the participant with the food.
FIGURE 3
Allergic reactions according to route of exposure. Other exposures included 3 allergic reactions with
other combinations, 1 unknown exposure, and 4 by injection (egg in influenza vaccine).
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children and evaluate single foods.5,20,22
In a 1-year retrospective study of 3 year
olds with milk allergy (n = 88) in Spain,
40% had 53 reactions,22 compared with
42.2% over the period of our study. In
a retrospective study of 252 Canadian
children (mean age 8.1 years) with
peanut allergy, an annual rate of 14.3%
was observed,20 compared with 6% in
our group. However, direct compar-
isons are limited by the different age
groups and study design. Advantages
of our study include a large cohort, a
prospective design, capturing reactions
to multiple foods, and a prolonged ob-
servation period. Caregivers in the current
investigation were not only aware of their
child’s food allergies, they also received
standardized milk, egg, and peanut avoid-
ance advice. Despite instruction, 72% of
participants experienced a reaction. It
should be noted that reactions to all foods
were collected in the study, but we chose
toprimarily focus onmilk, egg, andpeanut
because these were the foods to which
we had confirmed allergy in the former 2
with testing and advised families on
avoidance of all 3 allergens unless tol-
erance was confirmed. The majority of
reactions being to milk/egg might be
expected because these are ubiquitous
foods and the infants/children had these
common allergies.
The authors of previous studies have
identifiedspecificpitfalls inmanagement
but have methodological differences
from our study.5–7 Literature regarding
food-allergic reactions and response to
symptomsprimarily include retrospective
chart reviews,10,11 patient recall,6,12–14 or
oral food challenge data.15,16 Errors have
been identified including misreading lab-
els, poor communication in restaurants,
cross-contact of allergens, and lack of
vigilance.5–7 In our comprehensive pro-
spective study, we identified a number of
pitfalls, including novel ones (purposeful
exposure, high frequency of reactions
from food not provided by parents), and
their relative frequency, that warrant
attention for anticipatory guidance and
have implications for education (Table 4).
Nonaccidental (purposeful) ingestion
of known food allergens has so far only
been addressed and reported for teen-
agers with risk-taking behaviors.8,9 An
unexpected, worrisome finding in this
study is that 11% of milk, egg, or peanut
reactions resulted from these exposures.
In some cases, reactions occurred to a
food that was given in a larger amount
than before, which is a nuance worth
considering when taking a medical
history of young children with possible
TABLE 3 Symptom Severity, Medical Treatments, and Reasons for Not Using Epinephrine for Acute
Allergic Reactions by Food Allergen Type
All Food Allergen
Milk Egg Peanut Other
N % N % N % N % N %
Total reactions 1171 100.0 495 100.0 246 100.0 93 100.0 337 100.0
Symptom severity
Mild 821 70.1 347 70.1 189 76.8 57 61.3 228 67.7
Moderate 216 18.4 103 20.8 29 11.8 17 18.3 67 19.9
Severe 134 11.4 45 9.1 28 11.4 19 20.4 42 12.5
No treatment given 250 21.3 111 22.4 54 22.0 14 15.1 71 21.1
Epinephrine given 52 4.4 15 3.0 6 2.4 7 7.5 24 7.1
Antihistamines given 877 74.9 370 74.7 179 72.8 75 80.6 253 75.1
IV/oral steroids given 66 5.6 19 3.8 11 4.5 11 11.8 25 7.4
Topical steroids given 118 10.1 39 7.9 37 15.0 15 16.1 27 8.0
Asthma medication given 37 3.2 17 3.4 7 2.8 3 3.2 10 3.0
IV fluids given 6 0.5 2 0.4 1 0.4 1 1.1 2 0.6
Other treatment given 15 1.3 4 0.8 3 1.2 2 2.2 6 1.8
Reason epinephrine not given
for treated reactions (n = 869)
Reaction not severe enough 783 90.1 338 91.6 166 89.2 60 83.3 219 90.5
Reaction not recognized 31 3.6 13 3.5 9 4.8 2 2.8 7 2.9
Not available 15 1.7 6 1.6 4 2.2 3 4.2 2 0.8
Other 19 2.2 7 1.9 2 1.1 1 1.4 9 3.7
Unknown 21 2.4 5 1.4 5 2.7 6 8.3 5 2.1
TABLE 4 Key Study Findings and Management Implications for Infants/Young Children With
Proven or Likely Egg or Milk Allergy
Observation Clinical Implication for Anticipatory
Guidance/Education
The annualized rate or reactions for all foods
was 0.81 (95% CI: 0.76–0.85).
The high rate of reactions suggests the need
for increased education to avoid
reactions.
Most (64.9%) accidental allergic reactions
to milk, egg, or peanut were attributed
to lack of vigilance (failure to check ingredients,
forgetfulness, child taking the food, etc).
Emphasize need for supervision, checking
ingredients for each meal/snack.
Additional common errors in accidental
milk, egg, or peanut allergic reactions
include misreading labels (15.8%),
cross-contact in meal preparation (15.1%).
Educate about label-reading, avoiding
allergens inmeal preparation/restaurant
meals.
Half (50.6%) of all allergic reactions were
attributed to food not provided by parents,
including relatives and teachers.
Education should be given to all caretakers,
not just parents.
Purposeful trial of avoided milk, egg, or
peanut accounted for 11.2% of allergic
reactions to these foods.
Family shoulddiscussallergenre-introduction
before attempting on their own.
Overall, only 29.9% of reactions with
severe symptoms were treated with epinephrine.
Emphasize the symptoms that warrant
treatment with epinephrine.
Almost all severe reactions (94.8%) were
attributed to ingestion rather than other
routes of exposure (skin, inhalation).
Emphasis should be placed on avoidance of
oral exposure (including transfer from
hand to mouth in young children).
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food allergies. Reasons for these
exposures need further exploration
but may reflect parental testing for
resolution of allergy. A preemptive
discussion of the risks of purposeful
exposure is advisable.
As reported previously,20,23 there is a
hesitancy to administer epinephrine for
anaphylaxis. We found 65 reactions
where the caretaker failed to adminis-
ter epinephrine even though they felt it
was indicated. Education about treat-
ment and reassuring caretakers about
the safety of administering epineph-
rine24 is indicated because some care-
takers reported being afraid to use it.
We identified a number of baseline fac-
tors that were associated with having
reactions (Table 1). An association with
higher food-specific IgE supports ob-
servations that more sensitive children
are at risk25 but should not be construed
to warrant different care instructions
based upon IgE levels. We found a higher
rate of reactions among the children
with a greater number of food allergies,
a finding that might be expected based
upon probability. These and other asso-
ciations (eg, income, paternal education)
must be interpreted with caution as they
may reflect factors unique to the study
population but provide results of interest
for future studies on risk factors.
There is often concern that casual ex-
posure, such as skin contact or in-
halation (eg, via boiling milk), might
trigger severe reactions.7,26,27 However,
we found that the vast majority of se-
vere reactions were caused by isolated
ingestion, which emphasizes the in-
creased risks associated with inges-
tion compared with inhalation or skin
contact. Although severe reactions were
more likely to be caused by peanut, our
results indicate that severe reactions
can involve many other foods.
A common public perception is that re-
action severity increases with repeated
allergenexposure, anotion that remains
controversial.20,28–30 We found no sta-
tistical evidence that reactions worsen
with second exposure to the same
foods. For milk, there was some sug-
gestion that additional exposures had
worsening severity; there were too few
repeated reactions to egg and peanut to
address severity escalation. Our data
support the notion that subsequent re-
action severity is not easily predicted,
but more research is needed.
Limitations of the study include the
possibility that not all reactions were
captured, that parental reports included
inaccuracies about details, recall bias
since not all reactions were reported
immediately, and parents might have
been reluctant to report reactions to
purposeful exposures. The generaliz-
ability of the results is affected by the
enrollment criteria (a convenience
sample with likely egg/milk allergy
without known peanut allergy), and de-
mographic factors (mostly a middle
class, white population). Nonetheless,
the study focused upon the most com-
mon allergies in this age group, follow-
ing standard avoidance instructions. We
suspect that children with fewer visits
for food allergymay have higher rates of
reactions than we observed. Our rela-
tively lower rate of peanut reactions
could be attributed to the enrollment
criteria excluding known peanut allergy,
but given that most participants were
sensitized and many likely allergic, the
lower rate could also reflect more vigi-
lance; however, further studieswouldbe
needed to determine this possibility.
CONCLUSIONS
The results of this prospective study
revealed a high frequency of reactions
from accidental and nonaccidental ex-
posures. Basedupon the characteristics
of the reactions, areas requiring im-
proved education include anticipatory
guidance on persistent vigilance, accu-
rate label reading, prevention of cross-
contamination, avoidance of purposeful
exposures, and appropriate treatment of
allergic reactions. Subsequent reaction
severity was not easily predicted, and
ingestion, rather thanskinor inhalational
exposure, was responsible for almost all
severe reactions. With these data, the
pediatrician can provide management
instructions and anticipatory guidance
with new insights on potential pitfalls.
Additionally, the data provide guidance
toward improved educational programs
that should include all caregivers. Edu-
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